How is Holden Comprehensive Cancer Center different from other myeloma treatment centers?
The Myeloma Program at Holden Comprehensive Cancer Center is known for its tandem transplant protocol, a treatment approach offered at very few medical centers around the country. Research demonstrates that the median survival rate with this treatment process is 10 years or more and that 80% of newly-diagnosed myeloma patients will achieve complete remission. ... Read more
Myeloma News
Pomalidomide To Be Reviewed By FDA Advisory Committee
The U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee will review Celgene Corporation’s new drug application for pomalidomide at a meeting on November
Patient Stories
Part Two: Myeloma Doctor Becomes Myeloma Patient
Dr. Bruce Avery has a hematology and oncology practice in Knoxville, Tennessee, and treats multiple myeloma patients. When he himself was diagnosed with multiple myeloma a
Ask Dr. Tricot
What Should I Know About Multiple Myeloma with Amyloidosis?
Question: My sister-in-law was diagnosed with Stage 2 multiple myeloma as well as amyloidosis. Her kidneys failed and after blood and urine tests they suspected
